Career history of Ronald H. Abrahams
Former positions of Ronald H. Abrahams
| Companies | Position | Start | End |
|---|---|---|---|
Winston Laboratories, Inc.
 Winston Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL. | Chief Operating Officer | - | 2009-01-15 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 1993-12-31 | 1993-12-31 |
| ERGO SCIENCE CORPORATION | President | - | - |
| REATA PHARMACEUTICALS, INC. | Chief Operating Officer | - | - |
Training of Ronald H. Abrahams
| University of Illinois | Undergraduate Degree |
| Loyola University of Chicago | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private companies | 3 |
|---|---|
Winston Laboratories, Inc.
Winston Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Ergo Science Corp.
 Ergo Science Corp. Publishing: Books/MagazinesConsumer Services Ergo Science Corp. engages in the provision of business information. It operates indirectly through its subsidiaries. The company was founded on January 23, 1990 and is headquartered in Birmingham, AL. | Consumer Services |
- Stock Market
- Insiders
- Ronald H. Abrahams
- Experience
